icon- folder.gif   Conference Reports for NATAP  
 
  13th IAS Conference on HIV Science
IAS 2026
July 26-31 Rio, Brazil
 Back grey_arrow_rt.gif
 
 
 
Participants Report Positive Experiences Switching From Subcutaneous to Intravenous Lotivibart (LVB, N6LS, VH3810109) and Cabotegravir Long-Acting Injections for HIV-1 Treatment in EMBRACE Study
 
 
  IAS 2026 Rio, Brazil July 26-31

0807261copy

0807262copy

0807263copy

0807264copy

0807265copy

0807266copy

0807267copy

0807268copy